Citation only
via OpenAlex
HMGB2 Deficiency in Bone Marrow Mesenchymal Stem Cells Promotes Age‐Related Osteoporosis by Inhibiting Osteoblast Differentiation via Inflammatory Factors
Zhiliang Li, Yuqing Cai, Yao Lu, Baoshuo Qian, Wenxiu Yan, Hongwei Gao, Jing Zhao
The FASEB Journal · 2025 · ▲ 1 citations
Abstract
ABSTRACT With the global rise in osteoporosis due to aging, impaired osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) has emerged as a critical pathogenic factor. Although high mobility group box 2 (HMGB2) is implicated in BMSC aging and organismal senescence(definition), its mechanistic role in osteoporosis remains unclear. Here, we investigate HMGB2's regulatory effects on BMSC osteogenic differentiation under aging conditions. Using an H 2 O 2 ‐induced BMSC senescence model, we demonstrate that cellular senescence suppresses osteogenic differentiation, evidenced by reduced expression of osteogenic markers and diminished proliferation. Notably, HMGB2 overexpression reversed senescence‐mediated osteogenic impairment. In vivo studies of ovariectomy‐induced aging mice revealed a strong correlation between HMGB2 downregulation and osteoporosis progression, confirmed via immunohistochemistry. Mechanistically, HMGB2 promotes osteogenesis by directly suppressing TNF‐α and stabilizing the long non‐coding RNA TUG1, which subsequently inhibits pro‐inflammatory cytokines IL‐1β and IL‐6. This dual regulatory pathway highlights HMGB2's role in counteracting senescence‐driven osteogenic decline. Our study not only elucidates a novel HMGB2/TUG1 axis governing stem cell differentiation but also identifies HMGB2 as a promising therapeutic target for combating osteoporosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1096/fj.202500484rrrr
- Canonical
- link ↗
- Fetched
- 2026-10-18 MST
Cite this
APA
Li, Z., Cai, Y., Lu, Y., Qian, B., Yan, W., Gao, H., & Zhao, J. (2025). HMGB2 Deficiency in Bone Marrow Mesenchymal Stem Cells Promotes Age‐Related Osteoporosis by Inhibiting Osteoblast Differentiation via Inflammatory Factors. <em>The FASEB Journal</em>. https://doi.org/10.1096/fj.202500484rrrr
Vancouver
Li Z, Cai Y, Lu Y, Qian B, Yan W, Gao H, et al. HMGB2 Deficiency in Bone Marrow Mesenchymal Stem Cells Promotes Age‐Related Osteoporosis by Inhibiting Osteoblast Differentiation via Inflammatory Factors. The FASEB Journal. 2025. doi:10.1096/fj.202500484rrrr.
BibTeX
@article{zhiliang2025HMGBDe,
title = {HMGB2 Deficiency in Bone Marrow Mesenchymal Stem Cells Promotes Age‐Related Osteoporosis by Inhibiting Osteoblast Differentiation via Inflammatory Factors},
author = {Zhiliang Li and Yuqing Cai and Yao Lu and Baoshuo Qian and Wenxiu Yan and Hongwei Gao and Jing Zhao},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500484rrrr},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Bone and Mineral Research 2012
Open access · OA
DNA damage drives accelerated bone aging via an NF-<b>κ</b>B–dependent mechanism
Aging Cell 2021
Open access · CC-BY
Novel small molecule inhibition of IKK/NF‐κB activation reduces markers of senescence and improves healthspan in mouse models of aging
Aging Cell 2022
Open access · CC-BY
NAP1L2 drives mesenchymal stem cell senescence and suppresses osteogenic differentiation
Journal of Bone and Mineral Research 2016
Preprint · OA
Identification of Senescent Cells in the Bone Microenvironment
Cell Cycle 2009
Open access · OA
At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence
Stem Cells 2016
Open access · OA